...
首页> 外文期刊>The journal of immunology >Immunization with a Recombinant Adenovirus Encoding a Lymphoma Idiotype: Induction of Tumor-Protective Immunity and Identification of an Idiotype-Specific T Cell Epitope
【24h】

Immunization with a Recombinant Adenovirus Encoding a Lymphoma Idiotype: Induction of Tumor-Protective Immunity and Identification of an Idiotype-Specific T Cell Epitope

机译:用编码淋巴瘤特异型的重组腺病毒免疫:诱导肿瘤保护性免疫和识别特异型T细胞表位。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The Ig Id of a B cell lymphoma is a tumor-specific Ag, although as a self-Ag it is likely to be a weak immunogen. Provision of a foreign gene may enhance the immunogenicity of the idiotype. Viral vectors allow highly efficient transfer of genetic material and are themselves innately immunogenic. We have investigated the ability of recombinant adenoviral vectors, encoding the idiotypic gene with or without fusion to the human Fc region, to produce anti-idiotypic Ab- and T cell-mediated responses in a syngeneic BALB/c A20 murine lymphoma model. The idiotypic VH and VL sequences were assembled as a single chain variable fragment (scFv) and adenoviral vectors encoding the A20 scFv (Ad.A20) and A20 scFv linked to the Fc fragment of human IgG1 (Ad.A20hFc) were constructed. A single immunization of BALB/c mice with Ad.A20hFc but not Ad.A20 induced a specific anti-idiotypic Ab response. T cell lines generated from mice vaccinated with either vector displayed specific cytotoxicity, proliferation, and IFN-γ release against a syngeneic dendritic cell line transduced using a retroviral vector to express the A20 scFv idiotype (XS52.A1.A20). Importantly, both T cell lines lysed the A20 lymphoma cells. An immunodominant H-2Kd-restricted CD8+ T cell peptide, DYWGQGTEL (A20[106–114]), was identified as a naturally occurring A20 scFv epitope. A single immunization with Ad.A20hFc but not Ad.A20 provided protection in 40% of animals challenged with a lethal dose of the A20 tumor line and was more effective, in this model, than a previously optimized plasmid vaccine.
机译:B细胞淋巴瘤的Ig Id是肿瘤特异性的Ag,尽管作为自身Ag可能是一种弱免疫原。提供外源基因可以增强独特型的免疫原性。病毒载体允许遗传物质的高效转移,并且其本身具有固有的免疫原性。我们已经研究了重组腺病毒载体的能力,该腺病毒载体编码具有或没有与人Fc区融合的独特型基因,在同质BALB / c A20鼠淋巴瘤模型中产生抗独特型Ab和T细胞介导的应答。将独特型VH和VL序列组装成单链可变片段(scFv),并构建编码与人IgG1 Fc片段(Ad.A20hFc)连接的A20 scFv(Ad.A20)和A20 scFv的腺病毒载体。用Ad.A20hFc而不是Ad.A20单次免疫BALB / c小鼠可诱导特异性抗独特型Ab应答。从用两种载体接种的小鼠中产生的T细胞系对使用逆转录病毒载体转导表达A20 scFv独特型(XS52.A1.A20)的同系树突状细胞系表现出特异性的细胞毒性,增殖和IFN-γ释放。重要的是,两种T细胞系均裂解了A20淋巴瘤细胞。具有免疫优势的H-2Kd限制性CD8 + T细胞肽DYWGQGTEL(A20 [106–114])被鉴定为天然存在的A20 scFv表位。用Ad.A20hFc而不是Ad.A20进行单次免疫可在超过40%的致死剂量的A20肿瘤细胞攻击的动物中提供保护,并且在该模型中比以前优化的质粒疫苗更有效。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号